Department of Anaesthesia and Intensive Care of The 3rd Faculty of Medicine and Královské Vinohrady University Hospital Charles University Prague Czech Republic

Department of Anaesthesiology Intensive Care Emergency Medicine Transfusion Medicine and Pain Therapy University Hospital of Bielefeld Bielefeld Germany

Zobrazit více v PubMed

Balik M, Tavazzi G, Slama M (2014) Beta-blockers as antiarrhythmics in septic shock: a light at the end of the tunnel? Intensive Care Med. https://doi.org/10.1007/s00134-024-07713-z PubMed DOI

Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Morishima E, Matsuda N, J-Land 3S Study Group (2020) Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med 8(9):863–872. https://doi.org/10.1016/S2213-2600(20)30037-0 . (Epub 2020 Mar 31 PMID: 32243865) PubMed DOI

Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D, McAuley D, Singer M, Lord J, Gates S, Veenith T, MacCallum NS, Yeung J, Innes R, Welters I, Boota N, Skilton E, Ghuman B, Hill M, Regan SE, Mistry D, Lall R, STRESS-L Collaborators (2023) Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial. JAMA 330(17):1641–1652. https://doi.org/10.1001/jama.2023.20134 . (PMID: 37877587 PMCID: PMC10600724) PubMed DOI PMC

Rehberg S, Frank S, Černý V, Cihlář R, Borgstedt R, Biancofiore G, Guarracino F, Schober A, Trimmel H, Pernerstorfer T, Siebers C, Dostál P, Morelli A, Joannidis M, Pretsch I, Fuchs C, Rahmel T, Podbregar M, Duliczki É, Tamme K, Unger M, Sus J, Klade C, Krejcy K, Kirchbaumer-Baroian N, Krumpl G, Duška F, LANDI-SEP Study Group (2024) Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med 50(10):1622–1634. https://doi.org/10.1007/s00134-024-07587-1 . (Epub 2024 Sep 19 PMID: 39297945; PMCID: PMC11447033) PubMed DOI PMC

Klein Klouwenberg PM, Frencken JF, Kuipers S, Ong DS, Peelen LM, van Vught LA, Schultz MJ, van der Poll T, Bonten MJ, Cremer OL, MARS Consortium* (2017) Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis a cohort study. Am J Respir Crit Care Med 195(2):205–211. https://doi.org/10.1164/rccm.201603-0618OC . (PMID: 27467907.#) PubMed DOI

Arrigo M, Mebazaa A, Bettex D, Rudiger A (2020) Hemodynamic response of restoring sinus rhythm in critically ill patients with atrial fibrillation. Am J Emerg Med 38(6):1192–1194. https://doi.org/10.1016/j.ajem.2020.02.027 . (Epub 2020 Feb 19 PMID: 32093960) PubMed DOI

Bosch NA, Rucci JM, Massaro JM, Winter MR, Quinn EK, Chon KH, McManus DD, Walkey AJ (2021) Comparative effectiveness of heart rate control medications for the treatment of sepsis-associated atrial fibrillation. Chest 159(4):1452–1459. https://doi.org/10.1016/j.chest.2020.10.049 . (Epub 2020 Oct 24 PMID: 33619010 PMCID: PMC8039002) PubMed DOI

Balik M, Maly M, Brozek T, Rulisek J, Porizka M, Sachl R, Otahal M, Brestovansky P, Svobodova E, Flaksa M, Stach Z, Horejsek J, Volny L, Jurisinova I, Novotny A, Trachta P, Kunstyr J, Kopecky P, Tencer T, Pazout J, Belohlavek J, Duska F, Krajcova A, Waldauf P (2023) Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial. Intensive Care Med 49(11):1283–1292. https://doi.org/10.1007/s00134-023-07208-3 . (Epub 2023 Sep 12 PMID: 37698594) PubMed DOI

Waldauf P, Porizka M, Horejsek J, Otahal M, Svobodova E, Jurisinova I, Maly M, Brozek T, Rulisek J, Trachta P, Tencer T, Krajcova A, Duska F, Balik M (2024) The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume. Eur Heart J Acute Cardiovasc Care 13(5):414–422. https://doi.org/10.1093/ehjacc/zuae023 . (PMID: 38372622) PubMed DOI

Levy B, Slama M, Lakbar I, Maizel J, Kato H, Leone M, Okada M (2024) Landiolol for treatment of new-onset atrial fibrillation in critical care: a systematic review. J Clin Med 13(10):2951 PubMed DOI PMC

Krajčová A, Němcová V, Halačová M, Waldauf P, Balík M, Duška F (2023) Amiodarone but not propafenone impairs bioenergetics and autophagy of human myocardial cells. Toxicol Appl Pharmacol 477:116676. https://doi.org/10.1016/j.taap.2023.116676 . (Epub 2023 Sep 3 PMID: 37661063) PubMed DOI